Case number 2018-1241
Warner Chilcott (US), LLC v. Teva Pharmaceuticals USA, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | WARNER CHILCOTT (US), LLC v. TEVA PHARMACEUTICALS USA, INC. [RULE 36 JUDGMENT] [nonprecedential] (0) |
| Feb 20, 2019 | 66 | Mandate issued to the United States District Court for the Eastern District of Texas. Service as of this date by the Clerk of Court. [587343] [PBC] [Entered: 02/20/2019 09:46 AM] (2) |
| Feb 13, 2019 | 65 | ORDER filed denying [63] petition for panel rehearing filed by Allergan Sales, LLC and Qualicaps Co., Ltd.; denying [63] petition for en banc rehearing filed by Allergan Sales, LLC and Qualicaps Co., Ltd.. By: En Banc (Per Curiam). Service as of this date by the Clerk of Court. [585633] [PBC] [Entered: 02/13/2019 01:58 PM] (2) |
| Jan 15, 2019 | 64 | 18 paper copies of the petition for panel rehearing [63], petition for en banc rehearing [63] received from Appellants Allergan Sales, LLC and Qualicaps Co., Ltd. [578079] [JAB] [Entered: 01/15/2019 11:40 AM] (0) |
| Jan 11, 2019 | 63 | Petition for panel rehearing, for en banc rehearing filed by Appellants Allergan Sales, LLC and Qualicaps Co., Ltd.. Service: 01/11/2019 by email. The paper copies of the petition must be filed within two business days (see Fed. Cir. R. 35(c)(4).The required paper copies should be received by the court on or before 01/15/2019 [577626] [18-1241] [Michael Kennedy] [Entered: 01/11/2019 12:01 PM] (28) |
| Dec 12, 2018 | 62 | JUDGMENT filed. AFFIRMED. Issued pursuant to Federal Circuit Rule 36. Terminated on the merits after oral argument. COSTS: Costs taxed against Appellant(s). Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. [571105] [PBC] [Entered: 12/12/2018 09:31 AM] (2) |
| Dec 6, 2018 | 61 | Submitted after ORAL ARGUMENT by Mr. Michael N. Kennedy for Allergan Sales, LLC and Qualicaps Co., Ltd. and Mr. John Christopher Rozendaal for Teva Pharmaceuticals USA, Inc. Panel: Judge: Moore , Judge: Reyna , Judge: Chen. [569845] [JCP] [Entered: 12/06/2018 11:14 AM] (0) |
| Nov 15, 2018 | 60 | Response to oral argument order from the Appellants Allergan Sales, LLC and Qualicaps Co., Ltd..[565340] [18-1241] [Michael Kennedy] [Entered: 11/15/2018 01:41 PM] (3) |
| Nov 15, 2018 | 59 | Response to oral argument order from the Appellee Teva Pharmaceuticals USA, Inc..[565241] [18-1241] [John Rozendaal] [Entered: 11/15/2018 10:48 AM] (3) |
| Oct 22, 2018 | 58 | NOTICE OF ORAL ARGUMENT. Panel: 1812L. Case scheduled Dec 06, 2018 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, NW Washington, DC 20439), Courtroom 402. Response to Notice of Oral Argument due: 11/15/2018. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. [559161] [JAB] [Entered: 10/22/2018 01:46 PM] (2) |
| Sep 11, 2018 | 57 | ORDER filed. The motion [56] is granted to the extent that this appeal will be placed on the December 2018 oral argument calendar. Service: 09/11/2018 by clerk. [548833] [LMS] [Entered: 09/11/2018 02:38 PM] (2) |
| Sep 7, 2018 | 56 | MOTION of Appellee Teva Pharmaceuticals USA, Inc. to expedite hearing [Consent: unopposed]. Service: 09/07/2018 by email. [548226] [18-1241] [John Rozendaal] [Entered: 09/07/2018 05:24 PM] (8) |
| Sep 6, 2018 | 55 | Notice from Appellee Teva Pharmaceuticals USA, Inc. regarding conflicts with oral argument (November 7-9, 2018). Service: 09/06/2018 by email. [547741] [18-1241] [John Rozendaal] [Entered: 09/06/2018 03:37 PM] (2) |
| Jul 17, 2018 | 54 | Notice from Appellants Allergan Sales, LLC and Qualicaps Co., Ltd. regarding conflicts with oral argument (September 4-7 and November 7-9, 2018). Service: 07/17/2018 by email. [536516] [18-1241] [Michael Kennedy] [Entered: 07/17/2018 01:10 PM] (3) |
| Jul 13, 2018 | 53 | Notice from Appellee Teva Pharmaceuticals USA, Inc. regarding conflicts with oral argument (August 6-10, 2018). Service: 07/13/2018 by email. [535882] [18-1241] [John Rozendaal] [Entered: 07/13/2018 03:20 PM] (2) |
| Jul 10, 2018 | 52 | Pursuant to Practice Note 34, counsel should advise the clerk of court of scheduling conflicts for the next three court weeks, or thereafter. When filing the notice of conflicts, counsel should docket the Notice Regarding Conflicts with Argument Dates event, which is found in the Calendar event category. The notice of conflict with oral argument is due on or before 07/17/2018. [534823] [JB] [Entered: 07/10/2018 12:52 PM] (0) |
| May 31, 2018 | 51 | 6 paper copies of the Corrected Confidential Joint Appendix [50] received from Appellants Allergan Sales, LLC and Qualicaps Co., Ltd.. [525897] [CJF] [Entered: 05/31/2018 03:00 PM] (0) |
| May 25, 2018 | 50 | CORRECTED JOINT APPENDIX FILED for Allergan Sales, LLC and Qualicaps Co., Ltd. [47]. Number of Pages: 612. Service: 05/25/2018 by email. [524994] [CFT] [Entered: 05/29/2018 12:03 PM] (612) |
| May 25, 2018 | 49 | CORRECTED CONFIDENTIAL JOINT APPENDIX FILED for Allergan Sales, LLC and Qualicaps Co., Ltd. [48]. Number of Pages: 612. Service: 05/25/2018 by email. The paper copies of the brief should be received by the court on or before 06/05/2018. [524988]--[Edited 05/29/2018 by MJL to correct filed date]. [CFT] [Entered: 05/29/2018 11:53 AM] (0) |
| May 25, 2018 | 48 | TENDERED from Appellants Allergan Sales, LLC and Qualicaps Co., Ltd.. Title: CORRECTED CONFIDENTIAL JOINT APPENDIX Service: 05/25/2018 by email. [524816] [18-1241] [Michael Kennedy] [Entered: 05/25/2018 03:32 PM] (0) |
| May 25, 2018 | 47 | TENDERED from Appellants Allergan Sales, LLC and Qualicaps Co., Ltd.. Title: CORRECTED JOINT APPENDIX. Service: 05/25/2018 by email. [524809] [18-1241] [Michael Kennedy] [Entered: 05/25/2018 03:27 PM] (612) |
| May 18, 2018 | 46 | NOTICE OF REJECTION: The brief of Appellants Allergan Sales, LLC and Qualicaps Co., Ltd., Joint Appendix [43], [41], is not in compliance with the rules of this court and is therefore rejected for filing. Corrected Appendix is due 06/01/2018. Service as of this date by the Clerk of Court. [522704] [JB] [Entered: 05/18/2018 08:25 AM] (2) |
| May 15, 2018 | 45 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellants Allergan Sales, LLC and Qualicaps Co., Ltd.. Service: 05/15/2018 by email. [521986] [18-1241] [Michael Kennedy] [Entered: 05/15/2018 05:53 PM] (3) |
| May 15, 2018 | 44 | Joint Statement of Compliance with Fed. Cir. R. 33 for Appellants Allergan Sales, LLC, Qualicaps Co., Ltd. and Appellee Teva Pharmaceuticals USA, Inc.. Service: 05/15/2018 by email. [521985] [18-1241] [Michael Kennedy] [Entered: 05/15/2018 05:49 PM] (3) |
| May 15, 2018 | 43 | TENDERED from Appellants Allergan Sales, LLC and Qualicaps Co., Ltd.. Title: CONFIDENTIAL JOINT APPENDIX Service: 05/15/2018 by email. [521983] [18-1241] This brief has been rejected. See Doc No.[46] [Michael Kennedy] [Entered: 05/15/2018 05:46 PM] (0) |
| May 15, 2018 | 42 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellee Teva Pharmaceuticals USA, Inc.. Service: 05/15/2018 by email. [521982] [18-1241] [John Rozendaal] [Entered: 05/15/2018 05:43 PM] (4) |
| May 15, 2018 | 41 | TENDERED from Appellants Allergan Sales, LLC and Qualicaps Co., Ltd.. Title: JOINT APPENDIX. Service: 05/15/2018 by email. [521980] [18-1241] This brief has been rejected. See Doc No. [46] [Michael Kennedy] [Entered: 05/15/2018 05:38 PM] (0) |
| May 14, 2018 | 40 | 6 paper copies of the Reply Brief [39] received from Appellants Allergan Sales, LLC and Qualicaps Co., Ltd.. [521370] [CJF] [Entered: 05/14/2018 12:29 PM] (0) |
| May 8, 2018 | 39 | REPLY BRIEF FILED for Appellants Allergan Sales, LLC and Qualicaps Co., Ltd. [38]. Number of Pages: 29. Service: 05/08/2018 by email. The paper copies of the brief should be received by the court on or before 05/16/2018. Appendix is due 05/15/2018. [520419] [JB] [Entered: 05/09/2018 02:48 PM] (41) |
| May 8, 2018 | 38 | TENDERED from Appellants Allergan Sales, LLC and Qualicaps Co., Ltd.. Title: REPLY BRIEF. Service: 05/08/2018 by email. [520170] [18-1241] [Michael Kennedy] [Entered: 05/08/2018 05:26 PM] (41) |
| Apr 17, 2018 | 37 | 6 paper copies of the Opening Response Brief [36] received from Appellee Teva Pharmaceuticals USA, Inc. [514662] --[Edited 05/29/2018 by CAB to revise docket text] [JCP] [Entered: 04/18/2018 07:47 AM] (0) |
| Apr 10, 2018 | 34 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re: motion to extend time to file brief Docket No. [32], ERROR: The motion does not include a certificate of compliance regarding the word count. CORRECTION: For future motions, please include a certificate of compliance regarding the word count pursuant to FRAP 32(g)(1). THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [512081] [CFT] [Entered: 04/10/2018 01:53 PM] (0) |
| Apr 10, 2018 | 33 | **TEXT ONLY** ORDER granting motion to extend time to file brief [32] filed by Appellants Allergan Sales, LLC and Qualicaps Co., Ltd. Reply brief is due 05/08/2018. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [512078] [CFT] [Entered: 04/10/2018 01:52 PM] (0) |
| Apr 10, 2018 | 35 | TENDERED from Appellee Teva Pharmaceuticals USA, Inc.. Title: RESPONSE BRIEF. Service: 04/10/2018 by email. [512205] [18-1241] [John Rozendaal] [Entered: 04/10/2018 04:34 PM] (55) |
| Apr 10, 2018 | 36 | BRIEF FILED for Appellee Teva Pharmaceuticals USA, Inc. [35]. Number of Pages: 44. Service: 04/10/2018 by email. The paper copies of the brief should be received by the court on or before 04/20/2018. [513132] [JB] [Entered: 04/13/2018 09:32 AM] (55) |
| Apr 9, 2018 | 32 | MOTION of Appellants Allergan Sales, LLC and Qualicaps Co., Ltd. to extend the time to 05/08/2018 to file the Appellants' Reply Brief, currently due April 24, 2018... Any response is due within 10 days of service. [Consent: unopposed]. Service: 04/09/2018 by email. [511761] [18-1241] [David Denuyl] [Entered: 04/09/2018 03:26 PM] (6) |
| Mar 5, 2018 | 31 | 6 paper copies of the Opening Brief [30] received from Appellants Allergan Sales, LLC and Qualicaps Co., Ltd. [502519] [SJL] [Entered: 03/05/2018 12:56 PM] (0) |
| Mar 1, 2018 | 30 | BRIEF FILED for Appellants Allergan Sales, LLC and Qualicaps Co., Ltd. [29]. Number of Pages: 42. Service: 03/01/2018 by email. The paper copies of the brief should be received by the court on or before 03/09/2018. Appellee Teva Pharmaceuticals USA, Inc. brief is due 04/10/2018. [502282] [CMP] [Entered: 03/02/2018 10:22 AM] (87) |
| Mar 1, 2018 | 29 | TENDERED from Appellants Allergan Sales, LLC and Qualicaps Co., Ltd.. Title: OPENING BRIEF. Service: 03/01/2018 by email. [502189] [Michael Kennedy] [Entered: 03/01/2018 05:19 PM] (87) |
| Jan 11, 2018 | 28 | REMINDER: All counsel of record are reminded of their responsibility per Fed. Cir. R. 47.4(a)and Fed. Cir. R. 47.3 to promptly submit an amended Certificate of Interest (COI) and/or Entry of Appearance (EOA) as information changes during the pendency of the appeal. Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. [488831] [JB] [Entered: 01/11/2018 08:18 AM] (0) |
| Dec 26, 2017 | 27 | ORDER filed. The motion to remove Teva Pharmaceutical Industries from the official caption [22] is granted. The motion to dismiss Mylan [26] is granted to the extent that it is designated as a defendant in the official caption. The revised official caption is reflected in the order. Service: 12/26/2017 by clerk. [485556] [LMS] [Entered: 12/26/2017 02:02 PM] (2) |
| Dec 21, 2017 | 26 | MOTION of Appellants Allergan Sales, LLC, Qualicaps Co., Ltd. and Appellees Mylan Inc., Mylan Laboratories Limited and Mylan Pharmaceuticals, Inc. to withdraw party, Mylan Pharmaceutical, Inc., Mylan Laboratories Limited, and Mylan, Inc., as a party to this appeal. Any response is due within 10 days of service [Consent: unopposed]. Service: 12/21/2017 by email. [484640] [Michael Kennedy] [Entered: 12/21/2017 10:37 AM] (12) |
| Dec 21, 2017 | 25 | Notice of Rejection to Appellants Allergan Sales, LLC, Qualicaps Co., Ltd. and Appellees Mylan Inc., Mylan Laboratories Limited and Mylan Pharmaceuticals, Inc., the following document(s): motion for other relief [24] is REJECTED for filing. Reason(s): Incorrect event used. Service: 12/21/2017 by clerk. [484595] [JB] [Entered: 12/21/2017 09:28 AM] (1) |
| Dec 20, 2017 | 24 | MOTION of Appellants Allergan Sales, LLC, Qualicaps Co., Ltd. and Appellees Mylan Inc., Mylan Laboratories Limited and Mylan Pharmaceuticals, Inc. Dismiss Appeal with Prejudice only as to Mylan Appellees. Any response is due within 10 days of service [Consent: unopposed]. Service: 12/20/2017 by email. [484499] [Michael Kennedy] [Entered: 12/20/2017 05:52 PM] (12) |
| Dec 20, 2017 | 23 | **TEXT ONLY** ORDER granting motion to extend time to file appellant principal brief [21] filed by Appellants Allergan Sales, LLC and Qualicaps Co., Ltd. Brief is due 03/01/2018. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [484050] [JB] [Entered: 12/20/2017 08:12 AM] (0) |
| Dec 19, 2017 | 22 | MOTION of Appellee Teva Pharmaceuticals USA, Inc. to modify the official caption. Any response is due within 10 days of service [Consent: unopposed]. Service: 12/19/2017 by email. [483986] [John Rozendaal] [Entered: 12/19/2017 05:16 PM] (14) |
| Dec 19, 2017 | 21 | MOTION of Appellants Allergan Sales, LLC and Qualicaps Co., Ltd. to extend the time to 03/01/2018 at 11:59 pm to file the appellant/petitioner's principal brief. Any response is due within 10 days of service [Consent: unopposed]. Service: 12/19/2017 by email. [483856] [Michael Kennedy] [Entered: 12/19/2017 03:21 PM] (10) |
| Dec 18, 2017 | 20 | OVERDUE NOTICE to counsel for Appellee Teva Pharmaceutical Industries Ltd: The record of this case indicates that no attorney has entered an appearance for appellee Teva Pharmaceutical Industries Ltd. Also no Certificate of Interest or Docketing Statement has been filed. The required filings must be entered promptly in accordance with Fed. Cir. R. 47.3. Service as of this date by Clerk of Court. [483266] [JB] [Entered: 12/18/2017 11:30 AM] (0) |
| Dec 15, 2017 | 19 | Entry of appearance for Daniel J. Ritterbeck as of counsel for Appellee Teva Pharmaceuticals USA, Inc.. Service: 12/15/2017 by email. [483118] [Daniel Ritterbeck] [Entered: 12/15/2017 05:49 PM] (2) |
| Dec 15, 2017 | 18 | Entry of appearance for William H. Milliken as of counsel for Appellee Teva Pharmaceuticals USA, Inc.. Service: 12/15/2017 by email. [483117] [William Milliken] [Entered: 12/15/2017 05:47 PM] (2) |
| Dec 15, 2017 | 17 | Entry of appearance for Chandrika Vira as of counsel for Appellee Teva Pharmaceuticals USA, Inc.. Service: 12/15/2017 by email. [483116] [Chandrika Vira] [Entered: 12/15/2017 05:45 PM] (2) |
| Dec 15, 2017 | 16 | Entry of appearance for Michael E. Joffre as of counsel for Appellee Teva Pharmaceuticals USA, Inc.. Service: 12/15/2017 by email. [483114] [Michael Joffre] [Entered: 12/15/2017 05:43 PM] (2) |
| Dec 15, 2017 | 15 | Docketing Statement for the Appellee Teva Pharmaceuticals USA, Inc.. Service: 12/15/2017 by email. [483112] [John Rozendaal] [Entered: 12/15/2017 05:41 PM] (4) |
| Dec 15, 2017 | 14 | Certificate of Interest for the Appellee Teva Pharmaceuticals USA, Inc.. Service: 12/15/2017 by email. [483111] [John Rozendaal] [Entered: 12/15/2017 05:40 PM] (3) |
| Dec 15, 2017 | 13 | Entry of appearance for John Christopher Rozendaal as principal counsel for Appellee Teva Pharmaceuticals USA, Inc.. Service: 12/15/2017 by email. [483110] [John Rozendaal] [Entered: 12/15/2017 05:39 PM] (2) |
| Dec 15, 2017 | 12 | Entry of appearance for Mitchell G. Stockwell as of counsel for Appellees Mylan Inc., Mylan Laboratories Limited and Mylan Pharmaceuticals, Inc.. Service: 12/15/2017 by email. [483106] [Mitchell Stockwell] [Entered: 12/15/2017 05:11 PM] (1) |
| Dec 15, 2017 | 11 | Docketing Statement for the Appellees Mylan Inc., Mylan Laboratories Limited and Mylan Pharmaceuticals, Inc.. Service: 12/15/2017 by email. [483104] [David Holloway] [Entered: 12/15/2017 05:09 PM] (3) |
| Dec 15, 2017 | 10 | Certificate of Interest for the Appellees Mylan Inc., Mylan Laboratories Limited and Mylan Pharmaceuticals, Inc.. Service: 12/15/2017 by email. [483103] [David Holloway] [Entered: 12/15/2017 05:09 PM] (2) |
| Dec 15, 2017 | 9 | Entry of appearance for D. Clay Holloway as principal counsel for Appellees Mylan Inc., Mylan Laboratories Limited and Mylan Pharmaceuticals, Inc.. Service: 12/15/2017 by email. [483102] [David Holloway] [Entered: 12/15/2017 05:08 PM] (1) |
| Dec 15, 2017 | 8 | Entry of appearance for Philip S. May as of counsel for Appellants Allergan Sales, LLC and Qualicaps Co., Ltd.. Service: 12/15/2017 by email. [482962] [Philip May] [Entered: 12/15/2017 01:00 PM] (2) |
| Dec 15, 2017 | 7 | Entry of appearance for David S. Denuyl as of counsel for Appellants Allergan Sales, LLC and Qualicaps Co., Ltd.. Service: 12/15/2017 by email. [482961] [David Denuyl] [Entered: 12/15/2017 12:55 PM] (2) |
| Dec 15, 2017 | 6 | Entry of appearance for Jeremy D. Cobb as of counsel for Appellants Allergan Sales, LLC and Qualicaps Co., Ltd.. Service: 12/15/2017 by email. [482960] [Jeremy Cobb] [Entered: 12/15/2017 12:51 PM] (2) |
| Dec 15, 2017 | 5 | Entry of appearance for Jeffrey B. Elikan as of counsel for Appellants Allergan Sales, LLC and Qualicaps Co., Ltd.. Service: 12/15/2017 by email. [482959] [Jeffrey Elikan] [Entered: 12/15/2017 12:47 PM] (2) |
| Dec 15, 2017 | 4 | Docketing Statement for the Appellants Allergan Sales, LLC and Qualicaps Co., Ltd.. Service: 12/15/2017 by email. [482958] [Michael Kennedy] [Entered: 12/15/2017 12:42 PM] (3) |
| Dec 15, 2017 | 3 | Certificate of Interest for the Appellants Allergan Sales, LLC and Qualicaps Co., Ltd.. Service: 12/15/2017 by email. [482956] [Michael Kennedy] [Entered: 12/15/2017 12:40 PM] (3) |
| Dec 15, 2017 | 2 | Entry of appearance for Michael N. Kennedy as principal counsel for Appellants Allergan Sales, LLC and Qualicaps Co., Ltd.. Service: 12/15/2017 by email. [482944] [Michael Kennedy] [Entered: 12/15/2017 12:29 PM] (2) |
| Dec 1, 2017 | 1 | Appeal docketed. Received: 11/22/2017. [479545]Entry of Appearance due 12/15/2017. Certificate of Interest is due on 12/15/2017. Docketing Statement due 12/15/2017. Appellant/Petitioner's brief is due 01/30/2018. [JB] [Entered: 12/01/2017 10:39 AM] (86) |
